Ares CapitalRyan Specialty

Ares Capital vs Ryan Specialty

This page compares Ares Capital Corporation and Ryan Specialty Holdings Inc, exploring their business models, financial performance, and market context. It presents neutral, accessible explanations of...

Which Baskets Do They Appear In?

Wall Street's Private Credit Push

Wall Street's Private Credit Push

This carefully selected group of stocks represents companies positioned to benefit from the major shift toward private credit on Wall Street. Professional investors have identified these Business Development Companies as potential winners from JPMorgan's strategic move into alternative lending, which could drive new partnerships and increased deal flow.

Published: July 15, 2025

Explore Basket

Investment Analysis

Pros

  • Ares Capital is the largest publicly traded Business Development Company by market capitalization, providing scale advantages and market leadership.
  • The company has delivered a 13% annualized total shareholder return since its 2004 IPO, reflecting strong historic performance.
  • It generates steady income with a high dividend yield around 9.4%, supported by investments in senior secured loans and diversified debt/equity assets.

Considerations

  • Returns on assets and equity are moderate at about 4.9% and 10.3% respectively, indicating modest profitability.
  • The share price has shown modest volatility with a year-to-date decline and a current valuation near book value, suggesting limited price appreciation potential.
  • Its exposure to middle-market loans introduces credit risk sensitive to economic cycles and interest rate changes, posing potential downside risks.

Pros

  • Ryan Specialty Holdings operates in a growing specialty insurance services segment across multiple international regions providing revenue diversification.
  • The company recently issued $500 million in senior secured notes, indicating access to capital for potential growth investments.
  • Forward price-to-earnings ratio of 24.4 suggests market expectations for earnings improvement compared to its very high trailing P/E of 257.

Considerations

  • Ryan Specialty reported a net loss in the trailing twelve months with an EPS of -0.10, highlighting current profitability challenges.
  • Its stock trades with a very high P/E ratio, indicating elevated valuation risk if growth or earnings improvement disappoints.
  • The insurance specialty sector can be cyclical and exposed to regulatory and claims volatility, introducing uncertainty around earnings stability.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Ares CapitalSprott Physical Gold Trust

Ares Capital vs Sprott Physical Gold Trust

Ares Capital vs Sprott Physical Gold Trust

Ares CapitalEast West Bancorp

Ares Capital vs East West Bancorp

Ares Capital vs East West Bancorp

Erie IndemnityRyan Specialty

Erie Indemnity vs Ryan Specialty

Erie Indemnity vs Ryan Specialty

Frequently asked questions